Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About IAI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Infection and Immunity
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About IAI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Fungal and Parasitic Infections

Increased Levels of Soluble Fas Ligand in Serum inPlasmodium falciparum Malaria

Peter Kern, Manfred Dietrich, Christoph Hemmer, Nele Wellinghausen
Peter Kern
Section of Infectious Diseases and Clinical Immunology, University of Ulm, Ulm, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manfred Dietrich
Clinical Department, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christoph Hemmer
Clinical Department, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nele Wellinghausen
Section of Infectious Diseases and Clinical Immunology, University of Ulm, Ulm, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/IAI.68.5.3061-3063.2000
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Levels of soluble Fas ligand (sFasL) in serum were elevated in patients with Plasmodium falciparum malaria and showed a significant decline during disease course. sFasL levels that were elevated before antimalarial treatment began correlated significantly with depressed total lymphocyte and T-cell counts. These data suggest that Fas-induced apoptosis might play a role in malaria-associated lymphopenia.

In human malaria, a decrease in the number of circulating lymphocytes, particularly of the T-cell population, is frequent (7, 17). However, the pathophysiology of this lymphopenia is still unclear. Recent studies have shown that the level of spontaneous apoptosis in peripheral blood mononuclear cells is increased during acute malaria attacks (2). This could be attributed to the parasite itself, sincePlasmodium falciparum schizont-rich extract induces ex vivo apoptosis in peripheral blood mononuclear cells of affected patients (14). It is, therefore, assumed that decreased lymphocyte counts in malaria are caused by P. falciparum-induced apoptosis.

In this study, we investigated the possible involvement of the Fas-Fas ligand system in malaria-associated lymphopenia. We determined the level of soluble Fas ligand (sFasL) in the serum of 17 patients with acute P. falciparum malaria before the start of treatment and subsequently during disease course and compared it to that of age- and sex-matched healthy controls.

Serum samples of 17 patients with P. falciparum malaria (16 Europeans and 1 African immigrant who had lived in Germany for ≥2 years; 13 males and 4 females; mean age, 40 years; range, 16 to 61 years) who had already been subjects of a former study of tumor necrosis factor (TNF) receptors (6) were obtained at the Tropical Institute, Hamburg, Germany, in 1990. All subjects had contracted malaria while traveling in Africa. Malaria was diagnosed by examination of thick and thin blood films. Parasites in 2,000 erythrocytes were counted for the calculation of parasitemia. All patients received adequate antimalarial treatment. Five patients had to be classified as having severe malaria due to occurring complications: three suffered from impaired cerebral function (disorientation, drowsiness, and unconsciousness), one showed abnormal clotting tests (prothrombin time was <50% of the normal value and partial thromboplastin time was >45 s), and one showed severe anemia (hemoglobin was <7.5 g/dl).

Blood samples were taken on day 0 (before the onset of treatment), day 2, and day 7 of the disease. Serum samples were prepared immediately by centrifugation (2,000 × g) for 10 min, and aliquots were stored at −80°C until quantification of sFasL by enzyme-linked immunosorbent assay (Diaclone Research, Besançon, France). Lymphocyte count and subpopulations in EDTA-anticoagulated blood were determined by two-color flow cytometry (FACStar; Becton Dickinson, Heidelberg, Germany). Samples of blood from 17 age- and sex-matched healthy donors (13 males and 4 females; mean age, 42 years; range, 18 to 61 years), obtained in 1999 from the German Red Cross Blood Center in Ulm, Germany, served as controls. Samples from healthy donors were handled similarly to the patients' samples, but four-color flow cytometry analysis was performed with FACS Calibur (Becton Dickinson). For statistical interpretation, levels of significance were determined by nonparametric tests (Mann-Whitney rank sum U test and Wilcoxon signed-rank test, respectively). Spearman rank correlation coefficients (ρ) between different parameters were calculated.

Samples from patients with acute P. falciparum malaria had significantly increased levels of sFasL in serum as compared to controls (mean, 1,132.8 pg/ml [day 0] versus 36.5 pg/ml; P < 0.0001). During the disease course, sFasL levels significantly declined to a mean of 701.7 pg/ml on day 7 (day 0 versus day 2 and day 0 versus day 7, both P < 0.01) (Fig.1). This decline was associated with a normalization of the initially depressed total lymphocyte count, including T- and B-cell counts (Table 1). A significant negative correlation was found between initial sFasL levels on day 0 and both total lymphocyte and T-cell counts (ρ = −0.59 and P = 0.02 and ρ = −0.62 and P = 0.01, respectively) but not the B-cell count (Table1). The CD4/CD8 cell ratio did not change significantly during disease course, and there was no difference in the cell ratio between samples from the malaria patients and controls (data not shown). In contrast to lymphocyte count, total leukocyte and monocyte counts remained more or less stable during disease course (Table 1).

Fig. 1.
  • Open in new tab
  • Download powerpoint
Fig. 1.

(A) Levels of sFasL in serum (medians are indicated with horizontal lines) in 17 patients with acute malaria (day 0, before antimalarial treatment) in comparison to those in 17 healthy controls. (B) Levels of sFasL in serum during patients' disease course are shown. Box plots display the median and the 10th, 25th, 75th, and 90th percentiles as horizontal lines. Values outside the 10th and 90th percentiles are plotted as points (open circles).

View this table:
  • View inline
  • View popup
Table 1.

Cell populations of the malaria patients during disease course

Lymphocyte apoptosis is a regulatory mechanism of the immune system used to eliminate expanded lymphocyte populations in order to maintain cellular homeostasis. On the other hand, apoptosis may also be triggered by infectious agents in order to weaken the immune response (1). Activation of Fas, a so-called death receptor belonging to the same family as TNF, by FasL plays a major role in the induction of lymphocyte apoptosis (10, 16). While Fas is expressed in a variety of epithelial and hematopoietic cells, FasL is predominantly found on activated T cells and natural killer cells. Membrane-bound FasL can be cleaved by metalloproteinases to produce the soluble form (13). Our study showed significantly increased levels of sFasL in the serum of patients suffering from acute malaria as compared to samples from healthy donors. The origin of the detected increased levels of sFasL is, however, not clear. On the one hand, it might have been shed by activated FasL-bearing lymphocytes. On the other hand, it could also originate from endothelial cells, since FasL expression on vascular endothelial cells has been reported recently (8). Since systemic endothelial activation is observed in both mild and severe malaria (15), enhanced shedding of FasL from activated vascular endothelium may also be assumed.

In the present study, a significant correlation between enhanced sFasL levels and a depressed lymphocyte count was found. In accordance with earlier studies reporting T-cell depletion but normal levels of B cells in the serum of patients with malaria (17, 18), a significant correlation of sFasL levels was found in our study only with T- but not B-cell counts. These results suggest that Fas-induced apoptosis plays a role in the observed lymphopenia. However, although sFasL has been reported to induce apoptosis, there are also data reporting inhibition of membrane-bound FasL by sFasL (12, 13). Thus, by an increased shedding of FasL the apoptosis-inducing effect of membrane-bound FasL might be regulated and lymphopenia could even be limited. Interestingly, recent studies have shown that the activity of FasL is regulated by intracellular adhesion molecule 1 (ICAM-1) (11), which is also upregulated in malaria (3).

Since FasL has immunoregulatory functions and may even cause systemic tissue damage, like TNF (9, 13), it would be valuable to investigate a possible association between sFasL levels and the clinical status of the patients. However, we could include only three patients with severe malaria in our study and, therefore, significance of the data is very limited. Nevertheless, unlike TNF (4, 5) no correlation either with disease severity or with parasitemia was found (data not shown). This may be explained by the observation that, in contrast to TNF, Fas does not induce the activation of proinflammatory transcription factors such as NF-κB (10).

In summary, this study revealed increased levels of sFasL in the serum of patients with P. falciparum malaria which correlated significantly with depressed total lymphocyte and T-cell (CD3+) counts, suggesting that the Fas-FasL system plays a role in malaria-associated lymphopenia. Although functional data are still missing, these results provide the basis for further experimental and clinical studies addressing the mechanisms of lymphopenia in malaria.

Notes

Editor: W. A. Petri

FOOTNOTES

    • Received 20 December 1999.
    • Returned for modification 1 February 2000.
    • Accepted 19 February 2000.
  • Copyright © 2000 American Society for Microbiology

REFERENCES

  1. 1.↵
    1. Ameisen J. C.,
    2. Estaquier J.,
    3. Idziorek T.
    From AIDS to parasite infection: pathogen-mediated subversion of programmed cell death as a mechanism for immune dysregulation.Immunol. Rev.1421994951
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.↵
    1. Balde A. T.,
    2. Sathou J. L.,
    3. Roussilhon C.
    Acute Plasmodium falciparum infection is associated with increased percentages of apoptotic cells.Immunol. Lett.4619955962
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    1. Graninger W.,
    2. Prada J.,
    3. Neifer S.,
    4. Zotter G.,
    5. Thalhammer F.,
    6. Kremser P. G.
    Upregulation of ICAM-1 by Plasmodium falciparum: in vitro and in vivo studies.J. Clin. Pathol.471994653666
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Grau G. E.,
    2. Piguet P. F.,
    3. Vassalli P.,
    4. Lambert P. H.
    Tumor necrosis factor and other cytokines in cerebral malaria: experimental and clinical data.Immunol. Rev.11219894970
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    1. Kern P.,
    2. Hemmer C. J.,
    3. van Damme J.,
    4. Gruss H. J.,
    5. Dietrich M.
    Elevated tumor necrosis factor alpha and interleukin-6 serum levels as markers for complicated Plasmodium falciparum malaria.Am. J. Med.871989139143
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    1. Kern P.,
    2. Hemmer C. J.,
    3. Gallati H.,
    4. Neifer S.,
    5. Kremsner P.,
    6. Dietrich M.,
    7. Porzsolt F.
    Soluble tumor necrosis factor receptors correlate with parasitemia and disease severity in human malaria.J. Infect. Dis.1661992930934
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.↵
    1. Lisse I. M.,
    2. Aaby P.,
    3. Whittle H.,
    4. Knudsen K.
    A community study of T lymphocyte subsets and malaria parasitaemia.Trans. R. Soc. Trop. Med. Hyg.881994709710
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Sata M.,
    2. Walsh K.
    TNFalpha regulation of Fas ligand expression on the vascular endothelium modulates leukocyte extravasation.Nat. Med.41998415420
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.↵
    1. Schulze-Osthoff K.,
    2. Krammer P. H.,
    3. Droege W.
    Divergent signaling via APO-1/Fas and the TNF receptor, two homologous molecules involved in physiological cell death.EMBO J.13199445874596
    OpenUrlPubMedWeb of Science
  10. 10.↵
    1. Schulze-Osthoff K.,
    2. Ferrari D.,
    3. Los M.,
    4. Wesselborg S.,
    5. Peter M. E.
    Apoptosis signaling by death receptors.Eur. J. Biochem.2541998439459
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    1. Sieg S.,
    2. Smith D.,
    3. Kaplan D.
    Differential activity of soluble versus cellular Fas ligand: regulation by an accessory molecule.Cell. Immunol.19519998995
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Suda T.,
    2. Hashimoto H.,
    3. Tanaka M.,
    4. Ochi T.,
    5. Nagata S.
    Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligands blocks the killing.J. Exp. Med.12199720452050
    OpenUrl
  13. 13.↵
    1. Tanaka M.,
    2. Toshimitsu I.,
    3. Adachi M.,
    4. Nagata S.
    Downregulation of Fas ligand by shedding.Nat. Med.419983136
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.↵
    1. Toure-Balde A.,
    2. Sarthou J. L.,
    3. Aribot G.,
    4. Michel P.,
    5. Trape J. F.,
    6. Rogier C.,
    7. Roussilhon C.
    Plasmodium falciparum induces apoptosis in human mononuclear cells.Infect. Immun.641996744750
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Turner G. D.,
    2. Ly V. C.,
    3. Nguyen T. H.,
    4. Tran T. H.,
    5. Nguyen H. P.,
    6. Bethell D.,
    7. Wyllie S.,
    8. Louwrier K.,
    9. Fox S. B.,
    10. Gatter K. C.,
    11. Day N. P.,
    12. White N. J.,
    13. Berendt A. R.
    Systemic endothelial activation occurs in both mild and severe malaria. Correlating dermal microvascular endothelial cell phenotype and soluble cell adhesion molecules with disease severity.Am. J. Pathol.152199814771487
    OpenUrlPubMedWeb of Science
  16. 16.↵
    1. Vignauz F.,
    2. Golstein P.
    Fas-based lymphocyte-mediated cytotoxicity against synergic activated lymphocytes: a regulatory pathway? Eur. J. Immunol. 24 1994 923 927
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    1. Wells R. A.,
    2. Pavanand K.,
    3. Zolyomi S.,
    4. Permpanich B.,
    5. Macdermott R. P.
    Loss of circulating T lymphocytes with normal levels of B and “null” lymphocytes in Thai adults with malaria.Clin. Exp. Immunol.351979202209
    OpenUrlPubMed
  18. 18.↵
    1. Wyler D. J.
    Peripheral lymphocyte subpopulations in human falciparum malaria.Clin. Exp. Immunol.231976471476
    OpenUrlPubMed
PreviousNext
Back to top
Download PDF
Citation Tools
Increased Levels of Soluble Fas Ligand in Serum inPlasmodium falciparum Malaria
Peter Kern, Manfred Dietrich, Christoph Hemmer, Nele Wellinghausen
Infection and Immunity May 2000, 68 (5) 3061-3063; DOI: 10.1128/IAI.68.5.3061-3063.2000

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Infection and Immunity article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Increased Levels of Soluble Fas Ligand in Serum inPlasmodium falciparum Malaria
(Your Name) has forwarded a page to you from Infection and Immunity
(Your Name) thought you would be interested in this article in Infection and Immunity.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Increased Levels of Soluble Fas Ligand in Serum inPlasmodium falciparum Malaria
Peter Kern, Manfred Dietrich, Christoph Hemmer, Nele Wellinghausen
Infection and Immunity May 2000, 68 (5) 3061-3063; DOI: 10.1128/IAI.68.5.3061-3063.2000
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • Notes
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Malaria, Falciparum
Membrane Glycoproteins

Related Articles

Cited By...

About

  • About IAI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #IAIjournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0019-9567; Online ISSN: 1098-5522